Leopard spots can appear in a variety of diseases; however, they are extremely rare in children with rhegmatogenous retinal detachment. This study presents two such rare cases in which leopard spot retinopathy... … [Read more...] about Leopard spot retinopathy represents the initial sign of rhegmatogenous retinal detachment in children: a report of two cases
News
Cataract surgery: Top items in ophthalmology for 2024
December 17, 2024 1 min read The top cataract surgery items on Healio this year included updates on IOLs, robotic surgery systems and postoperative inflammation. Check out 2024’s top items on cataract surgery below. Check out 2024’s top items on cataract surgery. Image: Adobe Stock Q&A: Novel eye drop shows significant vision improvements in early cataracts … [Read more...] about Cataract surgery: Top items in ophthalmology for 2024
Regeneron announces aflibercept 8mg injection meets primary endpoint in phase 3 QUASAR trial in patients with retinal vein occlusion
Regeneron Pharmaceuticals has announced that the phase 3 QUASAR trial of EYLEA HD(aflibercept 8 mg) has met its primary endpoint.QUASAR is a global, double-masked, active-controlled phase 3 trial evaluating the efficacy and safety of EYLEA HD, compared to EYLEA, in patients with retinal vein occlusion (RVO), including those with central, branch, and hemiretinal vein occlusions. … [Read more...] about Regeneron announces aflibercept 8mg injection meets primary endpoint in phase 3 QUASAR trial in patients with retinal vein occlusion
European committee issues positive opinion for Eylea biosimilar
December 17, 2024 1 min read The Committee for Medicinal Products for Human Use of the European Medicines Agency granted a positive opinion for Eydenzelt, a biosimilar to Eylea, according to a press release from Celltrion. Eydenzelt (aflibercept 40 mg/mL) is recommended to treat wet age-related macular degeneration, macular edema following retinal vein occlusion, … [Read more...] about European committee issues positive opinion for Eylea biosimilar
Ask the Experts: What problem in ophthalmology do you wish there was a solution for?
This series features experts in ophthalmology sharing their thoughts on the one unsolved challenge they wish there was a solution for.Video Transcript:Editor's note: The below transcript has been lightly edited for clarity.Nathan Radcliffe, MD:If I could have a solution to one problem in ophthalmology, it would certainly be some sort of cure for glaucoma. If I could really … [Read more...] about Ask the Experts: What problem in ophthalmology do you wish there was a solution for?
Atsena completes dosing in part A of X-linked retinoschisis gene therapy trial
December 17, 2024 1 min read Atsena Therapeutics completed patient dosing in part A of the phase 1/2 LIGHTHOUSE clinical trial investigating a gene therapy designed for the treatment of X-linked retinoschisis, according to a press release. Part A of the trial is evaluating three dose levels of ATSN-201, a subretinal injection, in nine adults with X-linked retinoschisis … [Read more...] about Atsena completes dosing in part A of X-linked retinoschisis gene therapy trial
eyeDNA Therapeutics receives FDA Rare Pediatric Disease Designation for HORA-PDE6b, a novel gene therapy for PDE6b retinitis pigmentosa
eyeDNA Therapeutics announced it has been granted a Rare Pediatric Disease Designation (RPDD) by the FDA for HORA-PDE6b, its novel gene therapy for patients with inherited retinal dystrophy (IRD) caused by mutations of the PDE6b gene.PDE6b Retinitis Pigmentosa (PDE6b RP) is a rare inherited retinal dystrophy that affects an estimated 3000 individuals in the United States and … [Read more...] about eyeDNA Therapeutics receives FDA Rare Pediatric Disease Designation for HORA-PDE6b, a novel gene therapy for PDE6b retinitis pigmentosa
The human impact of geographic atrophy: Survey examines experiences and perceptions of patients living with GA
Geographic atrophy (GA), a progressive form of age-related macular degeneration (AMD), is a condition that causes irreversible damage to the retina, leading to the gradual loss of central vision. Patients diagnosed with GA must contend with the debilitating effects of this vision loss, which can profoundly impact their daily lives, emotional well-being, and overall quality of … [Read more...] about The human impact of geographic atrophy: Survey examines experiences and perceptions of patients living with GA
Specular microscopy: A practical guide for the assessment of corneal endothelial health and device selection
Reviewed by Ivo Guber, MD, FMH, FEBO, FICOSpecular microscopy is a valuable in-clinic tool for patients with corneal endothelial disease or who are undergoing corneal examination before other surgeries. Research data published earlier this year could help clinicians gain a better understanding of what to look for in a specular microscope, and how to interpret inter- and … [Read more...] about Specular microscopy: A practical guide for the assessment of corneal endothelial health and device selection
VIDEO: Prepare for challenges when discussing retirement with older colleagues
December 16, 2024 2 min watch CHICAGO — In this Healio Video Perspective from the AAO meeting, Alfredo A. Sadun, MD, PhD, of Doheny Eye Institute UCLA discusses when it may be time for an older ophthalmologist to consider retiring. Sadun shared an experience in which a cognitive dysfunction test was used to assess an older colleague and discussed the challenges that … [Read more...] about VIDEO: Prepare for challenges when discussing retirement with older colleagues